Literature DB >> 22819696

Low biopsy volume in ureteroscopy does not affect tumor biopsy grading in upper tract urothelial carcinoma.

Claudia P Rojas1, Scott M Castle, Cesar A Llanos, Janice A Santos Cortes, Vincent Bird, Senen Rodriguez, Isildinha M Reis, Wei Zhao, Carmen Gomez-Fernandez, Raymond J Leveillee, Merce Jorda.   

Abstract

OBJECTIVES: Urothelial carcinomas (UC) from the upper urinary tract represent 7%-10% of all kidney malignancies. With current ureteroscopic (URS) techniques, small tissue samples are usually the only available histopathologic material for evaluation, representing a diagnostic challenge. Precision in diagnosis is essential for treatment decision making. There has been much debate as to whether tumor grade and stage found on biopsy agree with final pathology. The purpose of this study is to evaluate whether URS biopsy volume affects tumor grading and staging agreement between biopsy and nephroureterectomy (NU) specimens.
MATERIALS AND METHODS: We reviewed 137 URS biopsies in 81 patients with suspected upper urinary tract UC performed from April 2002 to April 2011. Of those, 54 patients had both the URS biopsy and NU performed at our institution and were available for review. Biopsy dimensions were recorded to calculate estimated ellipsoid volume, and 2 urological pathologists independently evaluated histologic grade (ISUP/WHO 2004), (based on pleomorphism and mitosis) and depth of invasion. Statistical analysis was performed to evaluate URS biopsy and NU specimen grade and stage concordance. In addition, univariable and multivariable analyses was performed to assess the effect of biopsy volume on agreement.
RESULTS: Of the 54 patients studied, low grade and high grade UC biopsy were found in 8 (15%) and 46 (85%), URS biopsies, respectively. Regarding biopsy stage, 51 (94%), 1 (2%), and 2 (4%) were stage Ta, T1, T2, respectively. Grade concordance was 92.6%, (95% CI: 82.4%-98.0%). Stage concordance was 43% (95% CI: 28.7%-55.9%). Multivariable analysis showed biopsy volume did not affect tumor assessment of grade (P = 0.81) or stage (P = 0.44).
CONCLUSIONS: Histologic grade assigned on the URS biopsy sample accurately predicts histologic grade in the resected specimen (92.6%), even when the biopsy volume is small. Grading in URS biopsies provides sufficient information for clinical decision making that is independent of sample volume.
Copyright © 2013. Published by Elsevier Inc.

Entities:  

Keywords:  Nephroureterectomy; Upper urinary tract; Ureteroscopy; Urothelial carcinoma

Mesh:

Year:  2012        PMID: 22819696     DOI: 10.1016/j.urolonc.2012.05.010

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  18 in total

1.  A Novel Technique to Improve the Processing of Minute Ureteroscopic Biopsies.

Authors:  Shay Golan; Glenn Gerber; David Margel; Lea Rath-Wolfson; Yaron Ehrlich; Rumelia Koren; David Lifshitz
Journal:  Pathol Oncol Res       Date:  2017-04-03       Impact factor: 3.201

2.  Conservative treatment of upper urinary tract carcinoma: Long-term results.

Authors:  Andrea Orosa Andrada; Inés Laso García; Fernando Arias Fúnez; Francisco Donis Canet; Gemma Duque Ruiz; Victoria Gómez Dos Santos; Francisco Javier Burgos Revilla
Journal:  Can Urol Assoc J       Date:  2017-07-11       Impact factor: 1.862

Review 3.  Upper tract urothelial carcinoma: Paradigm shift towards nephron sparing management.

Authors:  Julia V Fiuk; Brad F Schwartz
Journal:  World J Nephrol       Date:  2016-03-06

Review 4.  Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC).

Authors:  Francesco Soria; Shahrokh F Shariat; Seth P Lerner; Hans-Martin Fritsche; Michael Rink; Wassim Kassouf; Philippe E Spiess; Yair Lotan; Dingwei Ye; Mario I Fernández; Eiji Kikuchi; Daher C Chade; Marko Babjuk; Arthur P Grollman; George N Thalmann
Journal:  World J Urol       Date:  2016-09-07       Impact factor: 4.226

Review 5.  Diagnostic challenges and treatment strategies in the management of upper-tract urothelial carcinoma.

Authors:  Victor M Schuettfort; Benjamin Pradere; Fahad Quhal; Hadi Mostafaei; Ekaterina Laukhtina; Keiichiro Mori; Reza Sari Motlagh; Michael Rink; David D'Andrea; Mohammad Abufaraj; Pierre I Karakiewicz; Shahrokh F Shariat
Journal:  Turk J Urol       Date:  2020-10-09

6.  Multi-institutional Evaluation of Upper Urinary Tract Biopsy Using Backloaded Cup Biopsy Forceps, a Nitinol Basket, and Standard Cup Biopsy Forceps.

Authors:  Daniel J Lama; Shoaib Safiullah; Roshan M Patel; Thomas K Lee; Jyoti P Balani; Lishi Zhang; Zhamshid Okhunov; Vitaly Margulis; Stephen J Savage; Edward Uchio; Jaime Landman
Journal:  Urology       Date:  2018-04-06       Impact factor: 2.649

7.  Using spatial-temporal ensembles of convolutional neural networks for lumen segmentation in ureteroscopy.

Authors:  Jorge F Lazo; Aldo Marzullo; Sara Moccia; Michele Catellani; Benoit Rosa; Michel de Mathelin; Elena De Momi
Journal:  Int J Comput Assist Radiol Surg       Date:  2021-04-28       Impact factor: 2.924

8.  Carcinoma in situ is significantly underdetected by prenephroureterectomy ureteroscopy in the management of upper tract urothelial cancers.

Authors:  Angela Gillan; Ismail El-Mokadem; Bhavan Rai; Stephen Lang; Jason Alcorn; Altaf Shams Ud Din; Ranan Dasgupta; Chandra Shekhar Biyani; Ghulam Nabi
Journal:  Biomed Res Int       Date:  2015-01-15       Impact factor: 3.411

9.  Diagnostic Ureteroscopy in CT Urography-Diagnosed Upper Tract Urothelial Carcinoma: Delay in Definitive Treatment and Increased Intravesical Recurrence.

Authors:  Hadi Shsm; Elizabeth Bright; Mark Mantle; Nicholas Munro; Omar Fahmy
Journal:  Cureus       Date:  2021-06-20

Review 10.  Nephron-sparing management of upper tract urothelial carcinoma.

Authors:  Jason M Farrow; Sean Q Kern; Gustavo M Gryzinski; Chandru P Sundaram
Journal:  Investig Clin Urol       Date:  2021-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.